Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Bertoletti

Showing results (31-40 of 224) with videos related to

Pageof 23
Sort By:
The Journal of General Virology|May 13, 2006
The immune response during hepatitis B virus infectionAntonio Bertoletti, Adam J Gehring
Gut|January 2, 2026
Recovery of HBV-specific B cell function after discontinuation of nucleos(t)ide analogue therapy: new insight and future challengesAntonio Bertoletti, Shubhankar Sunil Ambike
Journal of Hepatology|June 25, 2003
Translation of immunological knowledge into better treatments of chronic hepatitis BAntonio Bertoletti, Nikolai V Naoumov
Gut|March 15, 2023
Quest for immunological biomarkers in the management of CHB patientsAntonio Bertoletti, Nina Le Bert
Current Opinion in Immunology|May 4, 2020
HBV as a target for CAR or TCR-T cell therapyAntonio Bertoletti, Anthony Tanoto Tan
Immunology and Cell Biology|March 1, 2002
Control or persistence of hepatitis B virus: the critical role of initial host-virus interactionsGeorge Jm Webster, Antonio Bertoletti
Gut and Liver|January 11, 2018
Immunotherapy for Chronic Hepatitis B Virus InfectionAntonio Bertoletti, Nina Le Bert
Plos Pathogens|December 25, 2013
Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?Antonio Bertoletti, Adam J Gehring
The Journal of Experimental Medicine|March 13, 2020
Challenges of CAR- and TCR-T cell-based therapy for chronic infectionsAntonio Bertoletti, Anthony Tanoto Tan
Immunotherapy Advances|August 3, 2022
HBV-HCC treatment with mRNA electroporated HBV-TCR T cellsAnthony T Tan, Antonio Bertoletti
Pageof 23

Showing results (31-40 of 224) with videos related to

Sort By:
Pageof 23
The Journal of General Virology|May 13, 2006
The immune response during hepatitis B virus infectionAntonio Bertoletti, Adam J Gehring
Gut|January 2, 2026
Recovery of HBV-specific B cell function after discontinuation of nucleos(t)ide analogue therapy: new insight and future challengesAntonio Bertoletti, Shubhankar Sunil Ambike
Journal of Hepatology|June 25, 2003
Translation of immunological knowledge into better treatments of chronic hepatitis BAntonio Bertoletti, Nikolai V Naoumov
Gut|March 15, 2023
Quest for immunological biomarkers in the management of CHB patientsAntonio Bertoletti, Nina Le Bert
Current Opinion in Immunology|May 4, 2020
HBV as a target for CAR or TCR-T cell therapyAntonio Bertoletti, Anthony Tanoto Tan
Immunology and Cell Biology|March 1, 2002
Control or persistence of hepatitis B virus: the critical role of initial host-virus interactionsGeorge Jm Webster, Antonio Bertoletti
Gut and Liver|January 11, 2018
Immunotherapy for Chronic Hepatitis B Virus InfectionAntonio Bertoletti, Nina Le Bert
Plos Pathogens|December 25, 2013
Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?Antonio Bertoletti, Adam J Gehring
The Journal of Experimental Medicine|March 13, 2020
Challenges of CAR- and TCR-T cell-based therapy for chronic infectionsAntonio Bertoletti, Anthony Tanoto Tan
Immunotherapy Advances|August 3, 2022
HBV-HCC treatment with mRNA electroporated HBV-TCR T cellsAnthony T Tan, Antonio Bertoletti
Pageof 23